www.zerohedge.com by TYLER DURDEN
Pfizer CEO Albert Bourla’s global media tour continued this week with a series of interviews with the Israeli press. Of course, Israel has become an extremely important market for Pfizer. After all, they buy massive quantities of their vaccines.
A few weeks ago, Bourla was speaking with the French press, telling them he expected everything to “return to normal” by the Spring. France is of course another important customer for Pfizer’s vaccines. And with so much money at stake, it’s critical that a CEO must tend to propagate their preferred narrative with a carefully calculated global media strategy…
